Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$27.51 USD
-0.26 (-0.94%)
Updated May 24, 2024 04:00 PM ET
After-Market: $27.48 -0.03 (-0.11%) 6:46 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 33% (81 out of 249)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.42 | 9.99 |
Current Quarter Estimate | 0.37 | 1.25 | 57.00 |
Year Ago Quarter Estimate | -0.02 | -4.28 | 52.54 |
Next Quarter Estimate | 0.39 | 1.37 | 61.00 |
Next Year Estimate | 2.10 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8,650.00 | 17.60 | 15.67 |
Next Year | 20.00 | 15.50 | 9.31 |
Last 5 Years | -61.60 | 0.10 | 8.10 |
Next 5 Years | NA | 13.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 1.64 |
Price/Book (MRQ) | 1.64 | 1.44 |
Price/Cash Flow (MRFY) | 17.52 | 10.88 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -2.60% | -45.83% |
Return on Equity (TTM) | -1.68% | -58.31% |
Debt to Equity (MRQ) | 0.00 | 1.05 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.